Status:
RECRUITING
Response to Influenza Vaccination in Pediatric Oncology Patients
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Hematologic Malignancy
Pediatric Cancer
Eligibility:
All Genders
Up to 18 years
Brief Summary
Influenza infection occurring during oncologic treatment or following hematopoietic cell transplantation (HCT) is associated with increased risk of morbidity in the form of lower respiratory tract inf...
Detailed Description
This is a prospective, 2-stage, non-therapeutic study to characterize the immunogenicity of influenza vaccination among pediatric oncology patients at St. Jude. The first stage of the study will consi...
Eligibility Criteria
Inclusion
- Patient ≤ 18 years old at the time of consent receiving care at St. Jude Children's Research Hospital
- Diagnosed with a hematological malignancy
- Eligible to receive the current seasonal influenza vaccine
Exclusion
- • Previously received at least one dose of the current seasonal influenza vaccine.
Key Trial Info
Start Date :
October 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05384288
Start Date
October 7 2022
End Date
December 1 2027
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105